Smallcappower.com caught up with Mark Lackey at the 2014 Cantech Conference
held in Toronto. “Demand is rising for a lot of good tech stories and will
continue to do so,” says Mr. Lackey, Executive VP CHF Investor Relations.
“A number of these tech companies are either cash flow positive, have
earnings or are about to be,” says Mr. Lackey. He mentions one small cap
in particular that has a unique product to fight bladder cancer. Some of
the companies mentioned in this interview include Theralase Technologies
Inc. (TSXV: TLT).
